Table 3.
Genetic model association analysis with AA susceptibility (data shown for MASP2 and C11orf30 only).
| Gene | SNP | Model | Genotype | Controls (n, %) | Patients (n, %) | OR (95% CI) | P-value |
|---|---|---|---|---|---|---|---|
| MASP2 | rs2273346 | Codominant | A/A | 126 (85.1%) | 143 (94.1%) | 1.00 | 0.0026 |
| A/G | 22 (14.9%) | 7 (4.6%) | 0.28 (0.12–0.68) | ||||
| G/G | 0 (0%) | 2 (1.3%) | NA (0.00-NA) | ||||
| Dominant | A/A | 126 (85.1%) | 143 (94.1%) | 1.00 | 0.0099 | ||
| A/G-G/G | 22 (14.9%) | 9 (5.9%) | 0.36 (0.16–0.81) | ||||
| Recessive | A/A-A/G | 148 (100%) | 150 (98.7%) | 1.00 | 0.098 | ||
| G/G | 0 (0%) | 2 (1.3%) | NA (0.00-NA) | ||||
| C11orf30 | rs2155219 | Codominant | T/T | 43 (29.9%) | 31 (20.5%) | 1.00 | 0.0069 |
| G/T | 79 (54.9%) | 75 (49.7%) | 1.32 (0.75–2.30) | ||||
| G/G | 22 (15.3%) | 45 (29.8%) | 2.84 (1.43–5.64) | ||||
| Dominant | T/T | 43 (29.9%) | 31 (20.5%) | 1.00 | 0.064 | ||
| G/T-G/G | 101 (70.1%) | 120 (79.5%) | 1.65 (0.97–2.81) | ||||
| Recessive | T/T-G/T | 122 (84.7%) | 106 (70.2%) | 1.00 | 0.0027 | ||
| G/G | 22 (15.3%) | 45 (29.8%) | 2.35 (1.33–4.17) |